Rotate sites per usual GLP-1 injection protocols
While Mounjaro is not approved for weight loss, Eli Lilly was granted a fast-track designation for tirzepatide to treat people with obesity in October 2022
Saudi Arabia, UAE, and Kuwait are the primary Gulf GLP-1 markets, with both Novo Nordisk and Eli Lilly having established regional commercial operations and prescription support programs
In the SUSTAIN clinical trial program for type 2 diabetes, nausea was reported in approximately 15-20% of participants, while vomiting occurred in roughly 5-9% of patients receiving semaglutide, compared to lower rates in placebo groups
Moreover, studies demonstrate KPVs efficacy against Candida albicans and Staphylococcus aureus meaning it fights infection while reducing inflammation simultaneously
Animals that lack the GLP-1R do not show evidence of liraglutide in the ARC suggesting that peripherally administered liraglutide requires the GLP-1R to enter into the CNS (Secher et al., 2014)